Device Trial Radar · NCT04954898
Post-market Evaluation of Clinical Outcomes in China for the TECNIS Model ZMT
Last checked: Nov 20, 2026Latest source record: May 23, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
102
Actual
Start
Aug 11, 2021
Primary completion
Jan 10, 2024
Study completion Jan 10, 2024
Sponsor
- Lead sponsor
- Johnson & Johnson Surgical Vision, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 8, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective, multicenter, single-arm, open-label clinical study of the commercially available TECNIS Multifocal Toric 1-Piece IOL. The study will enroll up to 120 subjects from up to 8 sites in China. The subjects will be followed for 12-months postoperatively.
Conditions
- Cataract
Interventions
Study Lens: TECNIS Multifocal Toric 1-piece lens, Model ZMTDevice
Surgeons will perform standardized, small-incision, cataract surgery and implant the study lenses using a JJSV-validated insertion system qualified for use with TECNIS Multifocal Toric 1-Piece IOL.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The percentage of eyes that are measured at the 1-day postoperative visit to demonstrate ≤10º change from The intended IOL axis at the end of surgery.Time frame: 1 day postoperative
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Xiangya Hospital of Central South University
Kaifu, Changsha, China
Guangzhou Aier Eye Hospital
Guangzhou, Guangdong, China
Daqing Oil Field Central South University
Daqing, Heilongjiang, China
4 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.